A Long Term Follow-up Registry Study for Subjects Who Achieve A Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
ID Number 12-0514Principal Investigator(s)
Department(s) or Division(s)
The purpose of this study is to evaluate the response the subject had after they have completed participation in a Gilead-sponsored treatment study for hepatitis C. They may qualify to take part in this research study because they have previously participated in a Gilead-sponsored study for treating chronic hepatitis C (HCV) infection and they responded to that treatment. This study is a long term follow-up Registry study. No study medication will be administered. Their participation in this research study is expected to last up to 3 years.
Recruiting Patients: Yes